In the US, life sciences market research and insight consultancy KJT Group has appointed Arun Changolkar as Director of Health Outcomes Research.

Established in 2007, KJT Group employs nearly 50 full-time staff in New York, Pennsylvania, Texas, South Carolina and The Netherlands.

Changolkar joins with extensive academic and professional experience in health economics and outcomes research. During his career, he has held various positions including Director of Global Health Outcomes at Stiefel, and Manager of Health Outcomes and Analytics at GlaxoSmithKline. His experience includes the design and execution of HEOR studies to support multiple global country-specific reimbursement submissions, supporting clinical trials, and various other post-marketing observational studies.

Kenneth Tomaszewski, founder and CEO of KJT Group, comments: ‘Arun brings a very nice mix of skills and experience to our growing Health Outcomes Practice. Having worked on both the client and vendor sides he brings strong analytic skills as well as a clear understanding of the underlying business issues that our customers face.’

Web site: www.kjtgroup.com .

• Printer-friendly version of this article.
• Email this article to a friend.